The hnRNPA2/B1 interferes with the binding of Bcl-x pre-mRNA and Bcl-xs promotion factor Sam68, resulting in the blockade of Bcl-xs expression, thereby promoting tumour occurrence [46]. Here, BCL2L1 is linked to neoplasm.